Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. AZN
6. ROIV
7. AAPL
8. HOOD
9. QCOM
10. ACN

Go back to Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
(NASDAQ: BJDX) Delayed: 1.03 +0.20 (24.10%)
Previous Close $0.83    52 Week High $ 
Open $1.03    52 Week Low $ 
Day High $1.09    P/E N/A 
Day Low $0.91    EPS $ 
Volume 46,096,353